Zymvol x Aminoverse Partner on F&F Enzymes

Contact Author
Fill out my online form.

The two biotech companies expect to have their enzymes in the market by the second quarter of 2021.

Zymvol Biomodeling and Aminoverse, two biotech companies specializing in enzyme discovery and design, have partnered to develop custom-made alcohol dehydrogenases, a type of enzyme most commonly used in the flavors and fragrances and the fine chemicals industry.

Related: Market Report: Dairy Enzymes Market Expected To Increase

The collaboration aims to advance the design of better-performing enzymes via data-driven approaches. The companies expect to have their enzymes on the market by the second quarter of 2021.

Related: AB Vickers Develops ABV Aromazyme

The initiative is supported by the European Union’s research and innovation program.

The program's goals are:

• to keep improving proprietary technology by implementing artificial intelligence approaches;

• develop a computational pipeline for enzyme kits;

• and to develop proprietary enzymes.

According to Maria Fátima Lucas, CEO of Zymvol: “True progress in particularly difficult engineering campaigns render the need for out-of-the-box thinking, which is why we are joining efforts to advance industrial enzyme engineering beyond state of the art.”

“For the first time, we strive to provide a ‘data foundation’ to improve predictive accuracy of models and simulations,” stated David Schönauer, CEO of Aminoverse. “The challenges are two-fold: first, obtain data sets that are actually usable (i.e. all data points can be compared, the list is complete and descriptive); and second, actually make sense of the data to procure better predictions.”

Related Content